• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Editorial: COVID-19 booster vaccination: increasing immunity against life-threatening infection.社论：新冠病毒加强针接种：增强对危及生命感染的免疫力
Front Public Health. 2024 Jan 9;11:1342118. doi: 10.3389/fpubh.2023.1342118. eCollection 2023.
2
Follow-up SARS-CoV-2 serological study of a health care worker cohort following COVID-19 booster vaccination.新冠病毒加强疫苗接种后医护人员队列的后续严重急性呼吸综合征冠状病毒2血清学研究
BMC Infect Dis. 2024 Apr 24;24(1):436. doi: 10.1186/s12879-024-09338-5.
3
Strategies and safety considerations of booster vaccination in COVID-19.COVID-19 加强针接种的策略和安全性考虑。
Bosn J Basic Med Sci. 2022 Jun 1;22(3):366-373. doi: 10.17305/bjbms.2021.7082.
4
Vaccination after prior COVID-19 infection: Implications for dose sparing and booster shots.既往感染过新冠病毒后的疫苗接种：对剂量节省和加强针的影响。
EBioMedicine. 2021 Oct;72:103586. doi: 10.1016/j.ebiom.2021.103586. Epub 2021 Sep 15.
5
Impact of booster vaccination on the control of COVID-19 Delta wave in the context of waning immunity: application to France in the winter 2021/22.在免疫力下降的情况下加强疫苗接种对控制新冠病毒德尔塔毒株疫情的影响：以2021/22年冬季的法国为例
Euro Surveill. 2022 Jan;27(1). doi: 10.2807/1560-7917.ES.2022.27.1.2101125.
6
Omicron variant showed lower neutralizing sensitivity than other SARS-CoV-2 variants to immune sera elicited by vaccines after boost.奥密克戎变异株对疫苗加强后免疫血清的中和敏感性低于其他 SARS-CoV-2 变异株。
Emerg Microbes Infect. 2022 Dec;11(1):337-343. doi: 10.1080/22221751.2021.2022440.
7
T-Cell Mediated Response after Primary and Booster SARS-CoV-2 Messenger RNA Vaccination in Nursing Home Residents.养老院居民中初次接种和加强接种 SARS-CoV-2 信使 RNA 疫苗后的 T 细胞介导的反应。
J Am Med Dir Assoc. 2023 Feb;24(2):140-147.e2. doi: 10.1016/j.jamda.2022.11.024. Epub 2022 Dec 7.
8
Humoral immune response to authentic circulating severe acute respiratory syndrome coronavirus 2 variants elicited by booster vaccination with distinct receptor-binding domain subunits in mice.体液免疫应答对用不同受体结合域亚单位增强接种后循环中的真实严重急性呼吸综合征冠状病毒 2 变体的小鼠
J Med Virol. 2022 Sep;94(9):4533-4538. doi: 10.1002/jmv.27882. Epub 2022 Jun 3.
9
Durability of immune response after SARS-CoV-2 vaccination in patients with chronic liver disease.慢性肝病患者接种 SARS-CoV-2 疫苗后的免疫应答持久性。
Front Immunol. 2023 Jun 15;14:1200198. doi: 10.3389/fimmu.2023.1200198. eCollection 2023.
10
mRNA vaccine-induced T cells respond identically to SARS-CoV-2 variants of concern but differ in longevity and homing properties depending on prior infection status.mRNA 疫苗诱导的 T 细胞对 SARS-CoV-2 关切变异株的反应完全相同，但根据先前的感染状态，其持久性和归巢特性存在差异。
Elife. 2021 Oct 12;10:e72619. doi: 10.7554/eLife.72619.

引用本文的文献

1
The immunological impact of revaccination in a hybrid-immune world.在混合免疫的世界中再次接种疫苗的免疫学影响。
Front Immunol. 2025 Jun 9;16:1588259. doi: 10.3389/fimmu.2025.1588259. eCollection 2025.
2
Impact of Vaccination Status on COVID-19 Severity and Pulmonary Involvement.疫苗接种状况对COVID-19严重程度和肺部受累情况的影响。
Medicina (Kaunas). 2024 Nov 22;60(12):1919. doi: 10.3390/medicina60121919.

本文引用的文献

1
Impaired CD4 T cell response in older adults is associated with reduced immunogenicity and reactogenicity of mRNA COVID-19 vaccination.老年人中 CD4 T 细胞反应受损与 mRNA COVID-19 疫苗的免疫原性和反应原性降低有关。
Nat Aging. 2023 Jan;3(1):82-92. doi: 10.1038/s43587-022-00343-4. Epub 2023 Jan 12.
2
Antibody responses to COVID-19 vaccination in people with obesity: A systematic review and meta-analysis.肥胖人群对 COVID-19 疫苗接种的抗体反应：系统评价和荟萃分析。
Influenza Other Respir Viruses. 2023 Jan;17(1):e13078. doi: 10.1111/irv.13078. Epub 2022 Dec 19.
3
Efficacy and safety of COVID-19 vaccines.新型冠状病毒疫苗的有效性和安全性。
Cochrane Database Syst Rev. 2022 Dec 7;12(12):CD015477. doi: 10.1002/14651858.CD015477.
4
Safety and immunogenicity of a third dose of COVID-19 protein subunit vaccine (Covovax) after homologous and heterologous two-dose regimens.第三剂 COVID-19 蛋白亚单位疫苗（Covovax）在同源和异源两剂方案后的安全性和免疫原性。
Int J Infect Dis. 2023 Jan;126:64-72. doi: 10.1016/j.ijid.2022.11.022. Epub 2022 Nov 22.
5
Incidence of Severe COVID-19 Illness Following Vaccination and Booster With BNT162b2, mRNA-1273, and Ad26.COV2.S Vaccines.接种 BNT162b2、mRNA-1273 和 Ad26.COV2.S 疫苗后 COVID-19 重症发病情况。
JAMA. 2022 Oct 11;328(14):1427-1437. doi: 10.1001/jama.2022.17985.
6
Comparison of the reactogenicity and immunogenicity of a reduced and standard booster dose of the mRNA COVID-19 vaccine in healthy adults after two doses of inactivated vaccine.两剂灭活疫苗后，mRNA COVID-19 疫苗减少剂量和标准加强剂量在健康成年人中的反应原性和免疫原性比较。
Vaccine. 2022 Sep 16;40(39):5657-5663. doi: 10.1016/j.vaccine.2022.08.033. Epub 2022 Aug 22.
7
Immunogenicity of ChAdOx1-nCoV-19 vaccine in solid malignancy patients by treatment regimen versus healthy controls: A prospective, multicenter observational study.ChAdOx1-nCoV-19疫苗在实体恶性肿瘤患者中按治疗方案与健康对照相比的免疫原性：一项前瞻性、多中心观察性研究。
EClinicalMedicine. 2022 Oct;52:101608. doi: 10.1016/j.eclinm.2022.101608. Epub 2022 Aug 11.
8
Strong Correlations between the Binding Antibodies against Wild-Type and Neutralizing Antibodies against Omicron BA.1 and BA.2 Variants of SARS-CoV-2 in Individuals Following Booster (Third-Dose) Vaccination.加强（第三剂）疫苗接种后个体中针对野生型的结合抗体与针对新冠病毒奥密克戎BA.1和BA.2变体的中和抗体之间存在强相关性。
Diagnostics (Basel). 2022 Jul 22;12(8):1781. doi: 10.3390/diagnostics12081781.
9
Heterologous immunization with inactivated vaccine followed by mRNA-booster elicits strong immunity against SARS-CoV-2 Omicron variant.异源接种灭活疫苗后再接种 mRNA 加强针可诱导针对 SARS-CoV-2 奥密克戎变异株的强烈免疫应答。
Nat Commun. 2022 May 13;13(1):2670. doi: 10.1038/s41467-022-30340-5.
10
COVID-19 vaccines in patients with cancer: immunogenicity, efficacy and safety.癌症患者的 COVID-19 疫苗：免疫原性、疗效和安全性。
Nat Rev Clin Oncol. 2022 Jun;19(6):385-401. doi: 10.1038/s41571-022-00610-8. Epub 2022 Mar 11.

Editorial: COVID-19 booster vaccination: increasing immunity against life-threatening infection.

作者信息

Yorsaeng Ritthideach, Atsawawaranunt Kamolthip, Riad Abanoub

机构信息

Center of Excellence in Clinical Virology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.

King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok, Thailand.

出版信息

Front Public Health. 2024 Jan 9;11:1342118. doi: 10.3389/fpubh.2023.1342118. eCollection 2023.

DOI:10.3389/fpubh.2023.1342118
PMID:38264241
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10804992/
Abstract
摘要